ArticleFrontiers in neuroscience2025
Complex network behavior in epileptic patients treated with Vagus Nerve Stimulation (VNS): VNS responders exhibit a unique pattern, different from VNS non-responders and healthy controls.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Vagus nerve stimulation (VNS) represents an alternative treatment option in drug-resistant epilepsy. VNS patients can be categorized as responders (R, ≥50% seizure reduction) or non-responders (NR, < 50% seizure reduction). We demonstrate that VNS responders and VNS non-responders differ in their electrophysiological characteristics based on pre-implantation EEG analysis, specifically evaluated using relative mean power (RPW) and various information Entropy estimators computed in both he frequency and time domains. Based on the RPW and the Entropy estimators, we define and analyze the Unique Characteristics (UCs) of the individual (R and NR) groups of epileptic patients as well as Common Characteristics (CCs) that differentiate epileptic patients from healthy controls (HCs). Methods: We investigated pre-implantation time series in 59 epileptic patients treated with VNS (24 VNS responders, 35 VNS non-responders). Subsequently, we acquired the EEG time series for 37 age- and gender-matched HCs. The EEG recordings of these three groups were filtered into standard frequency bands (theta, alpha, beta, and gamma) and segmented into eight consecutive time intervals, containing specific types of stimulation and resting states. For each of these segments, the RPW and seven Entropy estimators were calculated. We focused on the distribution of features differentiating between the epileptic patients (VNS responders or non-responders) and the HCs. Results: We identified 41 UCs (7 in RPW, 34 in Entropy) of VNS responders, in contrast to 19 UCs (4 in RPW, 15 in Entropy) of VNS non-responders. The UCs of VNS responders exhibit a specific pattern, showing their binding in the frequency domain to the alpha band and temporal binding to the segments of hyperventilation stimulation. The UCs of VNS non-responders were also temporally linked to hyperventilation, but mainly in the theta and gamma frequency bands. Conclusion: The VNS responders exhibit more differences when compared to HCs than VNS non-responders. These differences can be observed in RPW, but they become more pronounced when Entropy analysis is applied. It seems that the distinct response to hyperventilation is present in both VNS responders and non-responders, differentiating them from HCs. However, the binding of this response to frequency bands differs among VNS responders and non-responders. In particular, the reaction among the VNS responders is strongly associated with the alpha frequency band.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.